Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 11950-11951 [2017-03733]

Download as PDF 11950 Federal Register / Vol. 82, No. 37 / Monday, February 27, 2017 / Notices Part 40 of title 10 of the Code of Federal Regulations (10 CFR), authorizes the NRC to issue a license to AUC for its Reno Creek Uranium In-Situ Recovery (ISR) Facility in Campbell County, Wyoming. Under conditions in the license, the Source and Byproduct Materials License SUA–1602 authorizes AUC to operate its facilities as proposed in its license application, as amended, and to possess uranium source and byproduct material at the Reno Creek ISR Facility. The NRC’s ROD that supports the decision to approve AUC’s license application for the Reno Creek ISR Facility and to issue the license is available in ADAMS under Accession No. ML17011A195. By letter dated October 3, 2012, AUC, LLC submitted a license application to the NRC for a Source and Byproduct Materials License for the in-situ 1 ...................... 2 ...................... 3 ...................... 4 5 6 7 8 9 ...................... ...................... ...................... ...................... ...................... ...................... 10 .................... 11 .................... 12 .................... 13 .................... [FR Doc. 2017–03807 Filed 2–24–17; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. mstockstill on DSK3G9T082PROD with NOTICES AGENCY: Notice of meeting. The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 26– 27, 2017. A sample of agenda items to VerDate Sep<11>2014 review process. The NRC’s Safety Evaluation Report documenting its review of AUC’s application was completed on September 30, 2016. The NRC issued its final environmental impact statement on December 16, 2016 In accordance with 10 CFR 2.390 of the NRC’s ‘‘Rules of Practice,’’ the details with respect to this action, including the Safety Evaluation Report and accompanying documentation and license, are available online in the ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/ adams.html. From this site, you can access the NRC’s Agencywide Document Access and Management System (ADAMS), which provides text and image files of the NRC’s public documents. The ADAMS accession numbers for the documents related to this notice are: Generic Environmental Impact Statement for In-Situ Leach Uranium Milling Facilities, May 2009 ............... AUC, LLC’s Application, October 3, 2012 ...................................................................................................... NRC email informing AUC that License Application Added to ADAMS and Deferral of Acceptance Review, November 30, 2012. NRC Request for Additional Information ......................................................................................................... Round 1—Response to Request for Additional Information, June 13, 2012 ................................................. NRC Results of Round 1 RAI Response Package, September 9, 2014 ....................................................... AUC Revised RAI Response Package, December 23, 2014 ......................................................................... Safety Evaluation Report, September 30, 2016 ............................................................................................. Environmental Impact Statement for the Reno Creek ISR Project in Campbell County, Wyoming, Supplement to the Generic Environmental Impact Statement for In-Situ Leach Uranium Milling Facilities, Draft Report for Public Comments, June 30, 2016. NUREG–1910, Suppl. 6, Environmental Impact Statement for the Reno Creek ISR Project in Campbell County, Wyoming, Supplement to the Generic Environmental Impact Statement for In-Situ Leach Uranium Milling Facilities, Final Report, December 2016. Source and Byproduct Materials License SUA–1602, February 16, 2017 ..................................................... NRC Staff’s Record of Decision, February 03, 2017 ...................................................................................... Safety Evaluation Report, Revision 1, February 16, 2017 ............................................................................. Dated at Rockville, Maryland, this 16th day of February 2017. For the Nuclear Regulatory Commission. Andrea Kock, Deputy Director, Division of Decommissioning, Uranium Recovery and Waste Programs, Office of Nuclear Material Safety and Safeguards. ACTION: extraction and recovery of uranium at its Reno Creek ISR Project in Campbell County, Wyoming. On November 30, 2012, the NRC staff acknowledged receipt of the application and noted that the application was placed in ADAMS) under Accession No. ML122890785. The NRC staff also noted that it could not commence its acceptance review until March 2013. The staff commenced the acceptance review in March 2013, and notified AUC on June 18, 2013, that the NRC staff had completed its acceptance review and found the application acceptable for detailed technical (safety) and environmental review. In addition to the application, the NRC staff held multiple public meetings with AUC to discuss various issues and submitted detailed requests for additional information to which AUC provided responses during the 20:23 Feb 24, 2017 Jkt 241001 be discussed during the public session includes: (1) An update on medicalrelated events; (2) a presentation by Elekta on the physical presence requirements for the Leksell Gamma Knife® IconTM; (3) an update on Category 3 source security and accountability evaluation initiatives; (4) a discussion on the training and experience requirements for authorized individuals for various modalities; (5) an update on the patient release project; (6) a discussion on the reporting of medical events for various modalities; (7) a discussion on patient intervention; and (8) a discussion on medical event reporting and impact on safety culture. The agenda is subject to change. The current agenda and any updates will be available at http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2017.html or by emailing Ms. Michelle Smethers at the contact information below. Purpose: Discuss issues related to title 10 of the Code of Federal Regulations PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 ML091530075 ML122890785 ML12349A262 ML13365A110 ML14169A452 ML14247A276 ML15002A077 ML16237A141 ML16181A082 ML16342A973 ML16364A219 ML17011A195 ML16364A227 (10 CFR) Part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: April 26, 2017, from 8:00 a.m. to 2:30 p.m. and April 27, 2017, from 8:00 a.m. to 3:45 p.m. Date and Time for Closed Sessions: April 26, 2017, from 7:30 a.m. to 8:00 a.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, Maryland 20852. Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Smethers using the information below. The meeting will also be webcast live: https:// video.nrc.gov/. PUBLIC PARTICIPATION: CONTACT INFORMATION: Michelle Smethers, email: michelle.smethers@ nrc.gov, telephone: (301) 415–0168. E:\FR\FM\27FEN1.SGM 27FEN1 Federal Register / Vol. 82, No. 37 / Monday, February 27, 2017 / Notices Conduct of the Meeting Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Smethers using the contact information listed above. All submittals must be received by April 21, 2017, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s Web site http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2017.html on or about June 14, 2017. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Smethers of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. Dated at Rockville, Maryland, this 21st day of February, 2017. For the Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2017–03733 Filed 2–24–17; 8:45 am] BILLING CODE 7590–01–P OVERSEAS PRIVATE INVESTMENT CORPORATION Sunshine Act Meeting Notice Thursday, December 8, 2016, 2 p.m. (OPEN Portion), 2:15 p.m. (CLOSED Portion). PLACE: Offices of the Corporation, Twelfth Floor Board Room, 1100 New York Avenue NW., Washington, DC. STATUS: Meeting OPEN to the Public from 2 p.m. to 2:15 p.m. Closed portion will commence at 2:15 p.m. (approx.). mstockstill on DSK3G9T082PROD with NOTICES TIME AND DATE: Matters to be Considered 1. President’s Report 2. Minutes of the Open Session of the September 15, 2016 Board of Directors Meeting Further Matters to be Considered (Closed to the Public 2:15 P.M.) 1. Insurance Project—Jordan VerDate Sep<11>2014 20:23 Feb 24, 2017 Jkt 241001 2. Insurance Project—Israel 3. Finance Project—Africa, South Asia 4. Finance Project—Africa 5. Minutes of the Closed Session of the September 15, 2016 Board of Directors Meeting 6. Reports 7. Pending Projects CONTACT PERSON FOR MORE INFORMATION: Information on the meeting may be obtained from Catherine F.I. Andrade at (202) 336–8768, or via email at Catherine.Andrade@opic.gov. Dated: November 9, 2016. Catherine F.I. Andrade, Corporate Secretary, Overseas Private Investment Corporation. [FR Doc. 2017–03905 Filed 2–23–17; 4:15 pm] BILLING CODE 3210–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–80076; File No. SR– NYSEArca–2016–89] Self-Regulatory Organizations; NYSE Arca, Inc; Notice of Designation of Longer Period for Commission Action on Proceedings To Determine Whether To Approve or Disapprove a Proposed Rule Change, as Modified by Amendment Nos. 1–4, To Amend the Co-location Services Offered by the Exchange To Add Certain Access and Connectivity Fees February 22, 2017. On August 16, 2016, NYSE Arca, Inc. (‘‘NYSE Arca’’ or the ‘‘Exchange’’) filed with the Securities and Exchange Commission (‘‘Commission’’), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 a proposed rule change to (1) provide additional information regarding access to various NYSE trading and execution services and establish fees for connectivity to certain NYSE market data feeds; and (2) provide and establish fees for connectivity to data feeds from third party markets and other content service providers; access to the trading and execution services of Third Party markets and other content service providers; connectivity to Depository Trust & Clearing Corporation services; connectivity to third party testing and certification feeds; and the use of virtual control circuits by Users in the Data Center. The Commission published the proposed rule change for comment in the Federal Register on August 26, 1 15 2 17 PO 00000 U.S.C. 78s(b)(1). CFR 240.19b–4. Frm 00061 Fmt 4703 Sfmt 4703 11951 2016.3 The Commission received no comments in response to the proposed rule change.4 On October 4, 2016, the Commission extended the time period within which to approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether to approve or disapprove the proposed rule change to November 24, 2016.5 On November 2, 2016, the Exchange filed Amendment No. 1 to the proposed rule change.6 On November 29, 2016, the Commission instituted proceedings to determine whether to approve or disapprove the proposed rule change, as modified by Amendment No. 1.7 Following the Order Instituting Proceedings, the Commission received several additional comment letters regarding the proposed rule change.8 On December 9, 2016, the Exchange filed Amendment No. 2 to the proposed rule change and on December 13, 2016 also 3 See Securities Exchange Act Release No. 34– 78628 (August 22, 2016), 81 FR 59004 (‘‘Notice’’). 4 The Commission notes that it did receive one comment letter on a related filing, NYSE–2016–45 (the ‘‘NYSE Companion Filing’’),which is equally relevant to this filing. See letter to Brent J. Fields, Secretary, Commission, from John Ramsay, Chief Market Policy Officer, Investors Exchange LLC (IEX), dated September 9, 2016 (‘‘IEX Letter’’). On September 23, 2016, the NYSE submitted a response (‘‘Response Letter I’’). 5 See Securities Exchange Act Release No. 34– 78967 (September 28, 2016), 81 FR 68480. 6 Amendment No. 1 is available on the Commission’s Web site at https://www.sec.gov/ comments/sr-nysearca-2016-89/nysearca2016891.pdf. 7 See Securities Exchange Act Release 34-79379 (November 22, 2016), 81 FR 86036. 8 See letter to Brent J. Fields, Commission, from Melissa MacGregor, Managing Director and Associate General Counsel, SIFMA, dated December 12, 2016 (‘‘SIFMA Letter I’’); letter to Brent J. Fields, Commission, from Joe Wald, Chief Executive Officer, Clearpool Group, dated December 16, 2016 (‘‘Clearpool Letter’’); letter to Brent J. Fields, Secretary, Commission, from John Ramsay, Chief Market Policy Officer, Investors Exchange LLC (IEX), dated December 21, 2016 (‘‘IEX Letter II’’); letter to Brent J. Fields, Commission, from Melissa MacGregor, Managing Director and Associate General Counsel, SIFMA, dated February 6, 2017 (‘‘SIFMA Letter II’’). All comments received by the Commission on the proposed rule change are available on the Commission’s Web site at: https:// www.sec.gov/comments/sr-nysearca-2016-89/ nysearca201689.shtml. The Commission notes that it did receive additional comment letters on the NYSE Companion Filing which are equally relevant to this filing. See letter to Brent J. Fields, Commission, from Adam C. Cooper, Senior Managing Director and Chief Legal Officer, Citadel Securities, dated December 12, 2016 (‘‘Citadel Letter’’); letter to Brent J. Fields, Commission, from David L. Cavicke, Chief Legal Officer, Wolverine LLC (‘‘Wolverine Letter’’); letter to Bent J. Fields, Secretary, Commission, from Stefano Durdic, Managing Director, R2G Services, LLC, dated January 21, 2017 (‘‘R2G Letter’’). All comments received by the Commission on the NYSE Companion Filing are available on the Commission’s Web site at: https://www.sec.gov/ comments/sr-nyse-2016-45/nyse201645.shtml. E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 82, Number 37 (Monday, February 27, 2017)]
[Notices]
[Pages 11950-11951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03733]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The U.S. Nuclear Regulatory Commission will convene a meeting of 
the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 
26-27, 2017. A sample of agenda items to be discussed during the public 
session includes: (1) An update on medical-related events; (2) a 
presentation by Elekta on the physical presence requirements for the 
Leksell Gamma Knife[supreg] IconTM; (3) an update on 
Category 3 source security and accountability evaluation initiatives; 
(4) a discussion on the training and experience requirements for 
authorized individuals for various modalities; (5) an update on the 
patient release project; (6) a discussion on the reporting of medical 
events for various modalities; (7) a discussion on patient 
intervention; and (8) a discussion on medical event reporting and 
impact on safety culture. The agenda is subject to change. The current 
agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html or by emailing Ms. Michelle 
Smethers at the contact information below.
    Purpose: Discuss issues related to title 10 of the Code of Federal 
Regulations (10 CFR) Part 35 Medical Use of Byproduct Material.
    Date and Time for Open Sessions: April 26, 2017, from 8:00 a.m. to 
2:30 p.m. and April 27, 2017, from 8:00 a.m. to 3:45 p.m.
    Date and Time for Closed Sessions: April 26, 2017, from 7:30 a.m. 
to 8:00 a.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.

PUBLIC PARTICIPATION: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Smethers using the information below. The meeting will also be webcast 
live: https://video.nrc.gov/.

CONTACT INFORMATION: Michelle Smethers, email: 
michelle.smethers@nrc.gov, telephone: (301) 415-0168.

[[Page 11951]]

Conduct of the Meeting

    Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Smethers using the contact information listed 
above. All submittals must be received by April 21, 2017, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2017.html on or about June 14, 2017.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Smethers of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland, this 21st day of February, 2017.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2017-03733 Filed 2-24-17; 8:45 am]
 BILLING CODE 7590-01-P